Celcuity CELC
NASDAQ CELC
$95.43 -1.00 (-1.04%)
As of: Sep 4, 2026 · 1:34 PM EDT

Celcuity (CELC) Other Non Operating Income (2020 - 2026)

Celcuity's (CELC) quarterly Other Non Operating Income came in at -$728756.0 in Q4 2024, up 32.92% YoY from -$548262.4 in Q1 2024, and down 371.81% on a QoQ basis from $268110.0 in Q3 2024.

Analysis

Celcuity (CELC) Other Non Operating Income (2020 - 2026) Analysis & Trends

Celcuity (CELC) has 5 years of Other Non Operating Income data on file, last reported at -$728756.0 in Q4 2024.

  • Quarterly Other Non Operating Income rose 32.92% year-over-year to -$728756.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $982000.0 (up 102.89% YoY) and the FY2025 annual result came in at $1.4 million, up 38.29% from the prior year.
  • Other Non Operating Income fell to -$728756.0 in Q4 2024, from $268110.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $881380.0 in Q1 2024 to a low of -$1.1 million in Q4 2023.
  • A 5-year average of -$39164.6 and a median of $443.0 in 2020 frame the typical range for Other Non Operating Income.
  • Annual changes were most pronounced in 2022 — Other Non Operating Income tumbled 418572.55% — and 2023, when it soared 297.27%.
  • Tracing CELC's Other Non Operating Income over 5 years: stood at $443.0 in 2020, then plunged by 97754.18% to -$432608.0 in 2021, then jumped by 113.37% to $57858.0 in 2022, then tumbled by 1977.73% to -$1.1 million in 2023, then soared by 32.92% to -$728756.0 in 2024.
  • The last three Other Non Operating Income figures came in at -$728756.0 (Q4 2024), $268110.0 (Q3 2024), and $561266.0 (Q2 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn
10 Celcuity 5.23 Bn 5.23 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11.48 Mn
Dec 31, 2024 -728,756.00
Sep 30, 2024 268,110.00
Jun 30, 2024 561,266.00
Mar 31, 2024 881,380.00
Dec 31, 2023 -1.02 Mn
Sep 30, 2023 493,497.00
Jun 30, 2023 467,798.00
Mar 31, 2023 609,120.00
Dec 31, 2022 2.38 Mn
Sep 30, 2022 -250,166.00
Jun 30, 2022 -359,799.00
Mar 31, 2022 -426,842.00
Dec 31, 2021 -432,608.00
Sep 30, 2021 -427,460.00
Jun 30, 2021 -389,384.00
Mar 31, 2021 102.00
Dec 31, 2020 443.00
Sep 30, 2020 5,777.00
Jun 30, 2020 11,952.00